col blocks we are bridge builder col blocks
COVID Antworten in den wissenschaftlichen Zeitschriften der Welt


35 Ergebisse       Seite 1

 [1] 
Wiley: Journal of Clinical Hypertension
  Original Artikel Datum Titel Autoren   Alle Autoren
1 [GO] 2025―Nov―26 Impact of COVID-19 Infection on Blood Pressure Variability and Cardiovascular Outcomes in Hypertensive Patients After Complete Liberalization of Epidemic Control in China Quanbin Su, Mingming Wang, Jing Yu
2 [GO] 2025―Jul―21 Lessons Learned From COVID-19: Never Lower the Guard in Promoting Hypertension Awareness Giacomo Pucci, Chiara Giacinti, Guido Grassi
3 [GO] 2025―Jul―21 Hypertension Prevalence, Awareness, and Control in US Adults Before and After the COVID-19 Pandemic Mohammed Essa, Devesh Malik, Yuan Lu, Huanhuan Yang, Erica S. Spatz, Harlan M. Krumholz, Kamil F. Faridi
4 [GO] 2025―Feb―26 Antihypertensive Drug Use and COVID-19 Disease Severity in Hospitalized US Veterans: A Retrospective Cohort Study Merodean Huntsman, Jessica L. Marquez, Gregory J. Stoddard, Guo Wei, Aaron J. Miller, Jayant P. Agarwal, Sujee Jeyapalina
5 [GO] 2025―Feb―17 Cardiac Baroreflex Is Preserved After the Recovery From COVID-19 Men and Women Roberto Souza, Beatriz Divino, Helena N. M. Rocha, Jocemir R. Lugon, Natalia G. Rocha, Antonio C. L. Nobrega, Eliza Prodel
6 [GO] 2024―Jul―14 Association between renin-angiotensin antagonism and COVID-19-related mortality in patients with essential hypertension: A single center, retrospective cohort study Vijayvardhan Kamalumpundi, Shuntaro Kawasaki, Linhai Cheng, Erin E. Meyers, Elham Shams, Ologibe Ofori, et al. (+2)
7 [GO] 2024―Jan―15 Trends in blood pressure changes and hypertension prevalence in Australian adults before and during the COVID-19 pandemic Janis M. Nolde, Fleur Streets, Denny Meyer, Won Sun Chen, Jiajun Wei, Nilmini Wickramasinghe, et al. (+3)
8 [GO] 2023―Mrz―15 Hypertension care during the COVID-19 pandemic in an integrated health care system John F. Steiner, J. David Powers, Allen Malone, Jason Lyons, Kari Olson, Andrea R. Paolino, Claudia A. Steiner
9 [GO] 2022―Mrz―21 Impact of more variations on in-hospital mortality among patients with confirmed Covid-19 Na Jia, Ping Zeng, Jun Xia, Deping Liu
10 [GO] 2022―Mrz―21 Temporal variation, socioeconomic status, and out-of-hospital deaths as factors that influence mortality rates among hospitalized COVID-19 patients receiving ACEIs/ARBs Owais M. Aftab, Anurag Modak, Jai C. Patel
11 [GO] 2022―Feb―07 Prognostic significance of day-by-day in-hospital blood pressure variability in COVID-19 patients with hypertension Chunyan He, Chuan Liu, Jie Yang, Hu Tan, Xiaohan Ding, Xubin Gao, et al. (+11)
12 [GO] 2022―Feb―07 Day-to-day blood pressure variability in COVID-19: A biomarker of disrupted central autonomic network Michiaki Nagai, Carola Yvette Förster
13 [GO] 2022―Jan―27 Mortality associated with COVID-19 and hypertension in sub-Saharan Africa. A systematic review and meta-analysis Ben Bepouka, Hippolyte Situakibanza, Modibo Sangare, Madone Mandina, Nadine Mayasi, Murielle Longokolo, et al. (+6)
14 [GO] 2021―Jul―31 Day-by-day blood pressure variability in hospitalized patients with COVID-19 Fei-Ka Li, De-Wei An, Qian-Hui Guo, Yi-Qing Zhang, Jia-Ye Qian, Wei-Guo Hu, et al. (+2)
15 [GO] 2021―Jul―30 Day-to-day blood pressure variability and severity of COVID-19: Is sympathetic overdrive a potential link? Michiaki Nagai, Takeshi Fujiwara, Kazuomi Kario
16 [GO] 2021―Jul―28 Influence of angiotensin converting enzyme inhibitors/angiotensin receptor blockers on the risk of all-cause mortality and other clinical outcomes in patients with confirmed COVID-19: A systemic review and meta-analysis Na Jia, Guifang Zhang, Xuelin Sun, Yan Wang, Sai Zhao, Wenjie Chi, et al. (+4)
17 [GO] 2021―Jun―25 Risk factors for the delayed viral clearance in COVID-19 patients Xiaoping Chen, Wenjia Hu MT, Miao Yang, Jiaxin Ling, Yongxi Zhang, Liping Deng, et al. (+4)
18 [GO] 2021―Mai―06 Arterial stiffness and COVID-19: A bidirectional cause-effect relationship Sahrai Saeed, Giuseppe Mancia
19 [GO] 2021―Feb―15 Advancing hypertension management in Asia 2021, beyond COVID-19 Aletta E. Schutte
20 [GO] 2021―Feb―03 Disaster hypertension and cardiovascular events in disaster and COVID-19 pandemic Keisuke Narita, Satoshi Hoshide, Kelvin Tsoi, Saulat Siddique, Jinho Shin, Yook-Chin Chia, et al. (+9)
21 [GO] 2021―Jan―25 Interactions between hypertension and inflammatory tone and the effect on blood pressure and outcomes in patients with COVID-19 Jacques Amar, Nicolas Touront, Antoine M. Ciron, Caroline Pendaries
22 [GO] 2020―Dez―25 The influence of diabetes and hypertension on outcome in COVID-19 patients: Do we mix apples and oranges? Marijana Tadic, Cesare Cuspidi
23 [GO] 2020―Dez―25 Is hypertension without any other comorbidities an independent predictor for COVID-19 severity and mortality? Martin R. Salazar
24 [GO] 2020―Dez―25 Independent and combined effects of hypertension and diabetes on clinical outcomes in patients with COVID-19: A retrospective cohort study of Huoshen Mountain Hospital and Guanggu Fangcang Shelter Hospital Yuhui Sun, Xizhou Guan, Lijing Jia, Ning Xing, Liuquan Cheng, Bo Liu, et al. (+2)
25 [GO] 2020―Nov―21 Hypertension, medications, and risk of severe COVID-19: A Massachusetts community-based observational study Ann Z. Bauer, Rebecca Gore, Susan R. Sama, Richard Rosiello, Lawrence Garber, Devi Sundaresan, et al. (+3)
26 [GO] 2020―Okt―25 COVID-19 and cardiovascular risk: Flying toward a silent world? Frédéric Dutheil, Julien S. Baker, Valentin Navel
27 [GO] 2020―Okt―02 Influence of blood pressure control and application of renin-angiotensin-aldosterone system inhibitors on the outcomes in COVID-19 patients with hypertension Renzheng Chen, Jie Yang, Xubin Gao, Xiaohan Ding, Yuanqi Yang, Yang Shen, et al. (+11)
28 [GO] 2020―Sep―20 COVID-19, hypertension, and renin-angiotensin-aldosterone system inhibitors: Much ado about nothing or real problem to be solved? Marijana Tadic, Cesare Cuspidi
29 [GO] 2020―Sep―16 Randomized elimination and prolongation of ACE inhibitors and ARBs in coronavirus 2019 (REPLACE COVID) Trial Protocol Jordana B. Cohen, Thomas C. Hanff, Vicente Corrales-Medina, Preethi William, Nicolas Renna, Nelson R. Rosado-Santander, et al. (+21)
30 [GO] 2020―Sep―03 Reduction in environmental noise during COVID-19 pandemic and cardiovascular disease: A mystery for further investigation Christina Antza, Stella Stabouli
31 [GO] 2020―Aug―28 Increased cardiovascular death rates in a COVID-19 low prevalence area Rita Del Pinto, Claudio Ferri, Leondino Mammarella, Stefano Abballe, Sofia Dell'Anna, Sabrina Cicogna, et al. (+3)
32 [GO] 2020―Jul―25 Use of distinct anti-hypertensive drugs and risk for COVID-19 among hypertensive people: a population-based cohort study in Southern Catalonia, Spain Angel Vila-Corcoles, Eva Satue-Gracia, Olga Ochoa-Gondar, Cristina Torrente-Fraga, Frederic Gomez-Bertomeu, Angel Vila-Rovira, et al. (+5)
33 [GO] 2020―Jul―09 COVID-19 and hypertension-evidence and practical management: Guidance from the HOPE Asia Network Kazuomi Kario, Yuji Morisawa, Apichard Sukonthasarn, Yuda Turana, Yook-Chin Chia, Sungha Park, et al. (+5)
34 [GO] 2020―Jul―06 COVID-19 and arterial hypertension: Hypothesis or evidence? Marijana Tadic, Cesare Cuspidi, Guido Grassi, Giuseppe Mancia
35 [GO] 2020―Mai―30 COVID-19 and diabetes: Is there enough evidence? Marijana Tadic, Cesare Cuspidi, Carla Sala
 [1] 

35 Ergebisse       Seite 1


[de][en]

Letzte Änderung 2025―Jul―29 14:55:09 UTC

© Daten-Quadrat 2022       Done in 0.016 sec